Bavarian Nordic Logo

Bavarian Nordic

A biotech firm developing and manufacturing life-saving vaccines for travel and public health.

BAVA | CO

Overview

Corporate Details

ISIN(s):
DK0015998017 (+1 more)
LEI:
2138006JCDVYIN6INP51
Country:
Denmark
Address:
PHILIP HEYMANS ALLE 3, 2900 HELLERUP
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bavarian Nordic is a fully integrated biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The company specializes in preventing infectious diseases through innovative vaccine technologies. It serves as a leading global provider of travel vaccines and is a key partner for governments and international organizations in delivering public health solutions. Bavarian Nordic manages the entire product lifecycle, from initial research and development through to large-scale manufacturing and distribution.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 13:29
Major Shareholding Notification
Danish 112.2 KB
2025-10-29 13:29
Major Shareholding Notification
English 2.9 KB
2025-10-29 13:29
Major Shareholding Notification
English 188.3 KB
2025-10-29 13:29
Major Shareholding Notification
Danish 2.8 KB
2025-10-21 14:46
M&A Activity
Danish 175.9 KB
2025-10-21 14:46
M&A Activity
Danish 20.5 KB
2025-10-21 14:46
M&A Activity
Danish 160.4 KB
2025-10-21 14:46
M&A Activity
English 20.0 KB
2025-10-21 14:46
M&A Activity
English 169.5 KB
2025-10-21 14:46
M&A Activity
English 186.1 KB
2025-10-16 07:28
M&A Activity
Danish 19.9 KB
2025-10-16 07:28
M&A Activity
English 19.4 KB
2025-10-16 07:28
M&A Activity
English 380.7 KB
2025-10-16 07:28
M&A Activity
English 161.7 KB
2025-10-16 07:28
M&A Activity
Danish 349.8 KB

Automate Your Workflow. Get a real-time feed of all Bavarian Nordic filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bavarian Nordic

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bavarian Nordic via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HIKMA Pharmaceuticals PLC Logo
Develops & markets affordable generic & specialty medicines for markets in NA, MENA, & Europe.
United Kingdom HIK
HISAMITSU PHARMACEUTICAL CO.,INC. Logo
A global leader in transdermal drug delivery systems for OTC and prescription pain relief.
Japan 4530
HLB Genex, Inc. Logo
Develops custom enzymes & microbiome solutions for diagnostics, nutrition, and cosmetic markets.
South Korea 187420
HLB INC. Logo
A diversified group in pharma, shipbuilding, life sciences, and professional advisory services.
South Korea 028300
HLB Life Science CO.,LTD. Logo
Develops anti-cancer drugs and distributes IVD medical devices and lab supplies internationally.
South Korea 067630
HLB PANAGENE Co., LTD. Logo
A global leader in PNA technology for cancer diagnostics and precision medicine.
South Korea 046210
HLB Pep Co., Ltd. Logo
Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.
South Korea 196300
HLB PHARMACEUTICAL CO., LTD. Logo
Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.
South Korea 047920
HLB SCIENCE Inc. Logo
Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.
South Korea 343090
H. Lundbeck A Logo
Develops and commercializes innovative therapeutics for brain diseases globally.
Denmark HLUN

Talk to a Data Expert

Have a question? We'll get back to you promptly.